fda decision tirzepatide fda shortage list tirzepatide The FDA's recent decision to remove tirzepatide from its shortage list has New Blockbuster Type 2 Medication

Tirzepatide, sold as Mounjaro and Zepbound, is a medication for type 2 diabetes and potential weight loss, respectively

This timeframe marks an important checkpoint to evaluate whether your current dose supports your goals, assess how your body has responded, and determine if additional optimizations might accelerate your results

This marks a new era in liver disease management reinforcing that treating #obesity is not only about short-term #weight loss, but also about long-term gains in metabolic and liver health

Nevertheless, aging is a privilege because we become wiser and more confident

But Eli Lilly is set its list price at 20% less than the other current GLP-1 medication options

Case presentation We report an 80-year-old male who presented with upper back pain for 3 months